A putative role for cathepsin K in degradation of AA and AL amyloidosis

American Journal of Pathology

Volumn 158, Issue 3, 2001, Pages 1029-1038

  Röcken, Christoph ^a   Stix, Barbara ^a   Brömme, Dieter ^b   Ansorge, Siegfried ^a   Roessner, Albert ^a   Bühling, Frank ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID A PROTEIN; AMYLOID PROTEIN; AMYLOID PROTEIN AL; CATHEPSIN K; UNCLASSIFIED DRUG;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; AUTOPSY; BIOPSY; CONTROLLED STUDY; FEMALE; GIANT CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 0035099113     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64050-3     Document Type: Article

References (48)

1. The classification of amyloid deposits in clinicopathological practice
2. Intralysosomal formation of amyloid fibrils
3. Ultrastructural evidence for intracellular formation of amyloid fibrils in macrophages
4. SAA) by murine macrophages in vitro. A light- and electronmicroscopic investigation
5. Amyloid in localised deposits and plasmacytomas of the respiratory tract
6. Primary localized amyloid tumor of the breast with osseous metaplasia
7. Localized amyloidosis of the uterine cervix
8. Amyloid tumours in the soft tissues of the legs. Case report and review of the literature
9. What is the role of giant cells in AL-amyloidosis
10. Amyloid resorption: Possible role of multinucleated giant cells. The apparent failure of penicillamine treatment
11. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors
12. The collagenolytic activity of cathepsin K is unique among mammalian proteinases
13. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts
14. Expression of cathepsin K in lung epithelial cells
15. Expression of cathepsin K in the human embryo and fetus
16. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction
17. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma
18. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells
19. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix
20. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates
21. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency
22. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization
23. Osteopetrosis and osteoporosis: Two sides of the same coin
24. Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex
25. An evaluation of antigen retrieval procedures for immunoelectron microscopical classification of amyloid deposits
26. Distribution pattern of matrix metalloproteinases (MMP-1, -2, -3, and -9), tissue inhibitors of matrix metalloproteinases (TIMP-1 and -2), and α 2-macroglobulin in cases of generalized AA and AL amyloidosis
27. Coincidence of breast cancer and amyloidosis of the breast: A report of two cases
28. Rosai-Dorfman disease and generalized AA amyloidosis. A case report
29. Plasmacytoma of the tonsil with secondary AL amyloidosis and osseous metaplasia
30. On the binding of Congo red by amyloid
31. The association of amyloid p-component (AP) with amyloid fibril: An updated method for amyloid fibril protein isolation
32. Tricine-sodium dodecyl sulphate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa
33. Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins
34. Serum amyloid A (SAA): Biochemistry, genetics and the pathogenesis of AA amyloidosis
35. Protein and host factors implicated in the pathogenesis of light chain amyloidosis (AL amyloidosis)
36. Fibril formation from recombinant human serum amyloid A
37. Direct evidence for SAA deposition in tissues during murine amyloidogenesis
38. The N-terminal segment of protein AA determines its fibrillogenic property
39. In vitro degradation of serum amyloid A by cathepsin D and other acid proteases: Possible protection against amyloid fibril formation
40. Accelerated amyloid deposition in mice treated with the aspartic protease inhibitor, pepstatin
41. Proteoglycans and amyloid fibrillogenesis
42. Proteoglycans and the extracellular matrix in amyloidosis
43. A high resolution ultrastructural study of experimental murine AA amyloid
44. Macromolecular properties of glycosaminoglycans in primary AL amyloid fibril extracts of lymphoid tissue origin
45. Amyloid P component. A critical review
46. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression
47. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis
48. Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology